intra-aortic balloon pump (IABP, intra-aortic balloon counterpulsation)
Jump to navigation
Jump to search
Pathology
- hemodynamic consequences of IABP are:
- decreased myocardial oxygen demand
- improved coronary artery blood flow
- reduced preload
- reduced afterload
Indications
Contraindications
- cardiogenic shock due to myocardial infarction
- no mortality benefit[3]
Procedure
- use of a balloon attached to a catheter inserted through the femoral artery into the descending thoracic aorta for producing alternating inflation & deflation during diastole & systole, respectively
Complications
More general terms
Additional terms
References
- ↑ Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, pg 124
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
- ↑ 3.0 3.1 Thiele H et al. for the IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012 Aug 27 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22920912 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1208410
O'Connor CM and Rogers JG. Evidence for overturning the guidelines in cardiogenic shock. N Engl J Med 2012 Aug 27 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22920913 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMe1209601